Skip to main content

Animations

MJFF Publications

2851 - 2860 of 8808 Results
Title
Year
  • Year
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • Summary Details
    RESTRICTED
    Title: New Questions About a Mysterious Neurologic Cluster in Canada
    Journal Name: Neurology Today
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1097/01.nt.0000792776.14362.2b
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Novel Genes May Drive Progression in Parkinson's Disease
    Journal Name: Neurology Today
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1097/01.nt.0000756456.16968.c1
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: The Parkinson's Detective, Caroline M. Tanner, MD, PhD, FAAN, on Environmental Factors and Prevention
    Journal Name: Neurology Today
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1097/01.nt.0000752844.66769.73
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: How to Increase Diverse Representation in Parkinson's Disease Trials
    Journal Name: Neurology Today
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1097/01.nt.0000805216.68841.48
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: For Some Neurologists, COVID-19 Has Prompted an ‘Existential Crisis’
    Journal Name: Neurology Today
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1097/01.nt.0000805196.94665.be
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: MS Study That Spans Decades Indicates Patients Benefit from Early Diagnosis and Treatment
    Journal Name: Neurology Today
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1097/01.nt.0000805208.98399.94
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: New Insights from a Two-Country Study Comparing Escalation Strategies for MS Drugs
    Journal Name: Neurology Today
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1097/01.nt.0000797988.61856.80
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Quality Improvement in Neurology
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000012198
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Prescribing Aducanumab in the Face of Meager Efficacy and Real Risks
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000012452
    Citation Count: 31
  • Summary Details
    OPEN
    Title: Cerebral Amyloid Angiopathy Is Associated With Emotional Dysregulation, Impulse Dyscontrol, and Apathy
    Journal Name: Journal of the American Heart Association
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1161/jaha.121.022089
    Citation Count: 18
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.